NPPA panel fixes the retail price of uncoated sustained-release tablets containing Medroxyprogesterone Acetate, details Dr. Divya Colin29 March 2022 6:27 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated sustained release tablet containing...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 7:02 PM ISTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
NPPA panel fixes retail price of Zydus healthcare's Glycopyrrolate, Formoterol,Budesonide metered-dose inhaler Dr. Divya Colin27 March 2022 12:30 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of Glycopyrrolate, Formoterol, and Budesonide...
Highest Ever: NPPA allows price hike of essential medicines by more than 10 percent Ruchika Sharma26 March 2022 5:48 PM ISTNew Delhi: In what can be termed as the highest price hike ever, the National Pharmaceutical Pricing Authority (NPPA), apex price regulatory body...
Presence of harmful bacteria at Similac production facility: USFDA probe Ruchika Sharma25 March 2022 4:11 PM ISTNo Cronobacter sakazakii was found during the company's testing of products that were distributed to the consumers, Abbott added.
Drug safety alert: IPC flags adverse reactions linked to Cephalosporin Susmita Roy24 March 2022 7:39 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed that...
Find alternative funding ways to set up new NIPERs: Parl Panel directs DoP MD Bureau23 March 2022 3:12 PM ISTA Parliamentary panel on Monday asked the Department of Pharmaceuticals to explore alternative ways of funding, including contribution from state...
Sun Pharma to acquire Daiichi's 11.28 percent stake in Zenotech MD Bureau22 March 2022 4:34 PM ISTAfter the acquisition, Sun Pharma's stake in Zenotech will increase from 57.56 percent to 68.84 percent.
Glenmark gets CDSCO panel nod for Phase 4 study of anti-diabetic FDC drug Dr. Divya Colin21 March 2022 6:37 PM ISTNew Delhi: In line with the drug major Glenmark Pharmaceutical's revised Phase IV clinical trial protocol for anti-diabetic fixed dose combination...
Present more data on unmet medical need for Tildrakizumab: CDSCO Panel tells Sun pharma Dr. Divya Colin20 March 2022 12:30 PM ISTNew Delhi: In response to the drug-major Sun Pharma's phase 3 protocol for immunomodulator Tildrakizumab, the Subject Expert Committee (SEC)...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
GSK gets CDSCO panel okay to conduct study on antineoplastic drug Belantamab Mafadotin Dr. Divya Colin18 March 2022 2:05 PM ISTNew Delhi: In a significant development, GSK Pharmaceuticals ( India) has got approval from the Subject Expert Committee (SEC) of the Central Drug...
